ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,276.38
0.91%
Dow Jones
42,518.28
0.00%
Gold vs US Dollar
2,686.905
0.69%
Brent Oil
79.825
0.16%
Bitcoin
98,863.56
2.45%
Pepperstone
Advertisement
Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Magenta Therapeutics Inc (MGTA)

  7. Magenta Therapeutics Inc (MGTA) News

Magenta Therapeutics (MGTA)

Magenta Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:MGTA
DateTimeSourceHeadlineSymbolCompany
16/09/202420:10Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:MGTAMagenta Therapeutics Inc
16/09/202420:06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MGTAMagenta Therapeutics Inc
13/09/202400:45Edgar (US Regulatory)Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:MGTAMagenta Therapeutics Inc
08/08/202420:26Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:MGTAMagenta Therapeutics Inc
08/08/202420:21Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:MGTAMagenta Therapeutics Inc
08/08/202420:10Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:MGTAMagenta Therapeutics Inc
08/08/202420:06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MGTAMagenta Therapeutics Inc
06/06/202412:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MGTAMagenta Therapeutics Inc
29/05/202400:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MGTAMagenta Therapeutics Inc
29/05/202400:04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MGTAMagenta Therapeutics Inc
29/05/202400:04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MGTAMagenta Therapeutics Inc
29/05/202400:02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MGTAMagenta Therapeutics Inc
28/05/202423:59Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MGTAMagenta Therapeutics Inc
28/05/202423:58Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MGTAMagenta Therapeutics Inc
28/05/202423:57Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MGTAMagenta Therapeutics Inc
28/05/202421:24Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:MGTAMagenta Therapeutics Inc
28/05/202421:20Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MGTAMagenta Therapeutics Inc
09/05/202420:27Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:MGTAMagenta Therapeutics Inc
09/05/202420:20Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:MGTAMagenta Therapeutics Inc
09/05/202420:08Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MGTAMagenta Therapeutics Inc
11/04/202420:10Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:MGTAMagenta Therapeutics Inc
11/04/202420:09Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:MGTAMagenta Therapeutics Inc
11/04/202420:05Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:MGTAMagenta Therapeutics Inc
01/04/202422:34Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:MGTAMagenta Therapeutics Inc
01/04/202422:21Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MGTAMagenta Therapeutics Inc
28/03/202404:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:MGTAMagenta Therapeutics Inc
21/03/202421:10Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:MGTAMagenta Therapeutics Inc
21/03/202421:02Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:MGTAMagenta Therapeutics Inc
21/03/202420:07Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:MGTAMagenta Therapeutics Inc
21/03/202420:04Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MGTAMagenta Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:MGTA

Your Recent History

BIT
UC2J35
Unicredit Bank
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2025 ADVFN PLC - All Rights Reserved

    Go Ad-Free

    Subscribe to Ad free and enjoy an ad-free experience

    No Ads

    Try Now

    Keep the Ads